KRRO - Korro Bio, Inc.

Insider Purchase by Walker Paul Edward (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Walker Paul Edward, serving as 10% owner at Korro Bio, Inc. (KRRO), purchased 207,100 shares at $11.11 per share, for a total transaction value of $2,300,881.00. Following this transaction, Walker Paul Edward now holds 1,297,893 shares of KRRO.

This purchase represents a 19.00% increase in Walker Paul Edward's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Korro Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Walker Paul Edward

10%

Paul Edward Walker is a prominent venture capitalist and 10% owner of SpyGlass Pharma, Inc. (SGP), a late-stage biopharmaceutical company focused on treatments for chronic eye conditions.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-f93027a43bc5.html)[[5]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP)[[8]](https://www.stifel.com/prospectusfiles/PD_9237.pdf) He filed an initial Form 3 on February 5, 2026, disclosing indirect holdings of multiple series of preferred stock in SGP, which converted to common stock ahead of the company's IPO.[[2]](https://www.streetinsider.com/SEC+Filings/Form+3+SpyGlass+Pharma,+Inc.+For:+Feb+05+Filed+by:+Walker+Paul+Edward/25954739.html)[[6]](https://www.stocktitan.net/sec-filings/SGP/form-3-spy-glass-pharma-inc-initial-statement-of-beneficial-ownership-f74dc886bb88.html) On February 9, 2026, entities linked to Walker indirectly purchased 937,500 shares of SGP common stock at $16 per share, increasing those holdings to approximately 6 million shares and solidifying his significant stake, reported as both director and beneficial owner (BO).[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-f93027a43bc5.html)[[3]](https://www.dataroma.com/m/ins/ins.php?t=y2&%3Bam=0&%3Bsym=AMC&%3Bo=fd&%3Bd=d&rid=1553150)[[5]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP) Walker is associated with New Enterprise Associates (NEA) funds, granting him substantial influence through indirect ownership, and has been highlighted alongside other major investors in recent SGP insider activities.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-f93027a43bc5.html)[[7]](https://www.tipranks.com/news/insider-trading/spyglass-pharma-insiders-make-a-massive-high-stakes-bet-on-the-companys-future-insider-trading)

View full insider profile →

Trade Price

$11.11

Quantity

207,100

Total Value

$2,300,881.00

Shares Owned

1,297,893

Trade Date

Tuesday, March 10, 2026

5 days ago

SEC Filing Date

Thursday, March 12, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Korro Bio, Inc.

Company Overview

No company information available
View news mentioning KRRO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4728358

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime